BioXcel Therapeutics
Price & Volume
Stats
See more52W Range | $1.17-$13.28 |
Market Cap | $52.2M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $868,000 |
Revenue Growth (YoY) | -89.1% |
Gross Profit (12 Mos) | -$1.2M |
Diluted EPS | -$12.66 |
News
See moreYahoo Finance • 21 days ago
BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements
Yahoo Finance • 29 days ago
BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia
Yahoo Finance • last month
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Yahoo Finance • last month
Which stocks are experiencing notable movement on Wednesday?
About
CEO | Dr. Vimal D. Mehta Ph.D. |
CFO | Mr. Richard I. Steinhart MBA |
Address | 555 Long Wharf Drive, New Haven, CT, United States, 06511 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 37 |
